Skip to main content

February 2019, Vol 12, No 1, Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective

Kenneth LaPensee, PhD; Rohit Mistry, MPharm, MBA, MSc; Thomas Lodise, PharmD, PhD

Results 1 - 1 of 1